Literature DB >> 20396534

Ergotism with ischemia in all four extremities: a case report.

Seok-Young Jeong1, Eui-Seong Lim, Byoung-Soo Shin, Man-Wook Seo, Young-Hyun Kim, Hyo-Sung Kwak, Gyung-Ho Chung, Seul-Ki Jeong.   

Abstract

Here we describe a case of ergotism that presented with ischemia in all four extremities. A 48-year-old man was admitted for pain and weakness in both upper extremities. He had a long history of migraine and had taken 3 mg of ergotamine daily for more than 21 years. Angiography demonstrated vasospasm involving all four extremities, which resolved partially following intra-arterial prostaglandin infusion. Intravenous nitroprusside was administered, and the patient stopped smoking and stopped taking ergotamine in an attempt to counteract the vasospasm. Follow-up computed tomography angiogram revealed that both brachial arteries had normalized. Thus, in this case of ergotism, severe vasospasm in all of the extremities was resolved with appropriate management.

Entities:  

Keywords:  Angiography; Ergotism; Vasospasm

Year:  2006        PMID: 20396534      PMCID: PMC2854981          DOI: 10.3988/jcn.2006.2.4.279

Source DB:  PubMed          Journal:  J Clin Neurol        ISSN: 1738-6586            Impact factor:   3.077


  10 in total

1.  EFNS guideline on the drug treatment of migraine - report of an EFNS task force.

Authors:  S Evers; J Afra; A Frese; P J Goadsby; M Linde; A May; P S Sándor
Journal:  Eur J Neurol       Date:  2006-06       Impact factor: 6.089

Review 2.  Ergotamine in the acute treatment of migraine: a review and European consensus.

Authors:  P Tfelt-Hansen; P R Saxena; C Dahlöf; J Pascual; M Láinez; P Henry; H Diener; J Schoenen; M D Ferrari; P J Goadsby
Journal:  Brain       Date:  2000-01       Impact factor: 13.501

Review 3.  Chronic daily headache.

Authors:  Stephen D Silberstein
Journal:  J Am Osteopath Assoc       Date:  2005-04

4.  Ergot induced peripheral vascular insufficiency, non-interventional treatment.

Authors:  T L McKiernan; K Bock; F Leya; E Grassman; B Lewis; S A Johnson; P J Scanlon
Journal:  Cathet Cardiovasc Diagn       Date:  1994-03

5.  Acute upper extremity ischemia during concomitant use of ergotamine tartrate and ampicillin.

Authors:  S Fukui; M Coggia; O Goëau-Brissonnière
Journal:  Ann Vasc Surg       Date:  1997-07       Impact factor: 1.466

6.  Cerebral manifestations of ergotism. Report of a case and review of the literature.

Authors:  H J Senter; A N Lieverman; R Pinto
Journal:  Stroke       Date:  1976 Jan-Feb       Impact factor: 7.914

7.  Chronic ergot toxicity: A rare cause of lower extremity ischemia.

Authors:  G D Garcia; J M Goff; N C Hadro; S D O'donnell; P S Greatorex
Journal:  J Vasc Surg       Date:  2000-06       Impact factor: 4.268

8.  Ergot intoxication: historical review and description of unusual clinical manifestations.

Authors:  G C Merhoff; J M Porter
Journal:  Ann Surg       Date:  1974-11       Impact factor: 12.969

9.  The patient with medication overuse: clinical management problems.

Authors:  F Frediani; A P Cannatà; A Magnoni; C Peccarisi; G Bussone
Journal:  Neurol Sci       Date:  2003-05       Impact factor: 3.307

10.  Recognition and treatment of arterial insufficiency from cafergot.

Authors:  K E Wells; D L Steed; A B Zajko; M W Webster
Journal:  J Vasc Surg       Date:  1986-07       Impact factor: 4.268

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.